Heparin Beyond Anticoagulation in Sepsis – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Patricia C Liaw et al, adding:
“The evolving role of heparin in sepsis: therapeutic potential in the age of immunothrombosis
Sepsis is marked by immunothrombosis, where inflammation, coagulation, endothelial injury, platelet activation, and NET formation drive both large and small vessel occlusion.
Heparin has re-emerged as a candidate because its actions reach beyond anticoagulation to anti-inflammatory, antimicrobial, and NET-modulating effects.
Trial evidence is limited, and COVID-19 data hint at benefit early and possible harm in advanced disease.”
Title: The evolving role of heparin in sepsis: therapeutic potential in the age of immunothrombosis
Authors: Patricia C Liaw, Ryan Zarychanski, Patrick R Lawler, Sylvain A Lother, Asher A Mendelson
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience